NM_021814.5:c.698A>G
Variant names: 
Variant summary
Our verdict is Benign. The variant received -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2
The NM_021814.5(ELOVL5):c.698A>G(p.Tyr233Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00103 in 1,614,126 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
 Genomes: 𝑓 0.00063   (  0   hom.,  cov: 32) 
 Exomes 𝑓:  0.0011   (  1   hom.  ) 
Consequence
 ELOVL5
NM_021814.5 missense
NM_021814.5 missense
Scores
 1
 8
 9
Clinical Significance
Conservation
 PhyloP100:  3.44  
Publications
9 publications found 
Genes affected
 ELOVL5  (HGNC:21308):  (ELOVL fatty acid elongase 5) This gene belongs to the ELO family. It is highly expressed in the adrenal gland and testis, and encodes a multi-pass membrane protein that is localized in the endoplasmic reticulum. This protein is involved in the elongation of long-chain polyunsaturated fatty acids. Mutations in this gene have been associated with spinocerebellar ataxia-38 (SCA38). Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Sep 2014] 
ELOVL5 Gene-Disease associations (from GenCC):
- spinocerebellar ataxia type 38Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -7 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.17183697). 
BP6
Variant 6-53270651-T-C is Benign according to our data. Variant chr6-53270651-T-C is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 210935.
BS2
High AC in GnomAd4 at 96 AD gene. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| ELOVL5 | NM_021814.5  | c.698A>G | p.Tyr233Cys | missense_variant | Exon 7 of 8 | ENST00000304434.11 | NP_068586.1 | |
| ELOVL5 | NM_001242828.2  | c.779A>G | p.Tyr260Cys | missense_variant | Exon 8 of 9 | NP_001229757.1 | ||
| ELOVL5 | NM_001301856.2  | c.698A>G | p.Tyr233Cys | missense_variant | Exon 7 of 8 | NP_001288785.1 | ||
| ELOVL5 | NM_001242830.2  | c.573A>G | p.Val191Val | synonymous_variant | Exon 6 of 7 | NP_001229759.1 | 
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| ELOVL5 | ENST00000304434.11  | c.698A>G | p.Tyr233Cys | missense_variant | Exon 7 of 8 | 1 | NM_021814.5 | ENSP00000306640.6 | ||
| ELOVL5 | ENST00000542638.5  | c.573A>G | p.Val191Val | synonymous_variant | Exon 6 of 7 | 1 | ENSP00000440728.2 | |||
| ELOVL5 | ENST00000370918.8  | c.779A>G | p.Tyr260Cys | missense_variant | Exon 8 of 9 | 2 | ENSP00000359956.5 | 
Frequencies
GnomAD3 genomes   AF:  0.000631  AC: 96AN: 152152Hom.:  0  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
96
AN: 
152152
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.000617  AC: 155AN: 251284 AF XY:  0.000604   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
155
AN: 
251284
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.00108  AC: 1572AN: 1461856Hom.:  1  Cov.: 31 AF XY:  0.00109  AC XY: 791AN XY: 727234 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
1572
AN: 
1461856
Hom.: 
Cov.: 
31
 AF XY: 
AC XY: 
791
AN XY: 
727234
show subpopulations 
African (AFR) 
 AF: 
AC: 
3
AN: 
33480
American (AMR) 
 AF: 
AC: 
9
AN: 
44724
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
26136
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
39688
South Asian (SAS) 
 AF: 
AC: 
14
AN: 
86258
European-Finnish (FIN) 
 AF: 
AC: 
54
AN: 
53416
Middle Eastern (MID) 
 AF: 
AC: 
3
AN: 
5768
European-Non Finnish (NFE) 
 AF: 
AC: 
1446
AN: 
1111992
Other (OTH) 
 AF: 
AC: 
43
AN: 
60394
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.480 
Heterozygous variant carriers
 0 
 82 
 164 
 247 
 329 
 411 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 54 
 108 
 162 
 216 
 270 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome   AF:  0.000630  AC: 96AN: 152270Hom.:  0  Cov.: 32 AF XY:  0.000551  AC XY: 41AN XY: 74448 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
96
AN: 
152270
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
41
AN XY: 
74448
show subpopulations 
African (AFR) 
 AF: 
AC: 
8
AN: 
41554
American (AMR) 
 AF: 
AC: 
4
AN: 
15294
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
0
AN: 
3470
East Asian (EAS) 
 AF: 
AC: 
0
AN: 
5182
South Asian (SAS) 
 AF: 
AC: 
0
AN: 
4820
European-Finnish (FIN) 
 AF: 
AC: 
10
AN: 
10606
Middle Eastern (MID) 
 AF: 
AC: 
0
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
72
AN: 
68024
Other (OTH) 
 AF: 
AC: 
2
AN: 
2114
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.504 
Heterozygous variant carriers
 0 
 4 
 8 
 13 
 17 
 21 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Variant carriers
 0 
 2 
 4 
 6 
 8 
 10 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
TwinsUK 
 AF: 
AC: 
5
ALSPAC 
 AF: 
AC: 
6
ESP6500AA 
 AF: 
AC: 
2
ESP6500EA 
 AF: 
AC: 
10
ExAC 
 AF: 
AC: 
59
EpiCase 
 AF: 
EpiControl 
 AF: 
ClinVar
Significance: Conflicting classifications of pathogenicity 
Submissions summary: Uncertain:1Benign:2 
Revision: criteria provided, conflicting classifications
LINK: link 
Submissions by phenotype
not specified    Uncertain:1 
Apr 07, 2015
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided    Benign:1 
Jul 03, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Spinocerebellar ataxia type 38    Benign:1 
Nov 18, 2019
Knight Diagnostic Laboratories, Oregon Health and Sciences University
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 AlphaMissense 
 Benign 
 BayesDel_addAF 
 Benign 
T 
 BayesDel_noAF 
 Benign 
 DANN 
 Uncertain 
 DEOGEN2 
 Uncertain 
.;T 
 Eigen 
 Uncertain 
 Eigen_PC 
 Uncertain 
 FATHMM_MKL 
 Uncertain 
D 
 LIST_S2 
 Benign 
D;D 
 M_CAP 
 Benign 
T 
 MetaRNN 
 Benign 
T;T 
 MetaSVM 
 Benign 
T 
 PhyloP100 
 PrimateAI 
 Uncertain 
T 
 PROVEAN 
 Pathogenic 
.;D 
 REVEL 
 Benign 
 Sift 
 Uncertain 
.;D 
 Sift4G 
 Uncertain 
T;T 
 Polyphen 
 0.90 
.;P 
 Vest4 
 MVP 
 ClinPred 
T 
 GERP RS 
 RBP_binding_hub_radar 
 RBP_regulation_power_radar 
 Varity_R 
 gMVP 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.